Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:10 pm Sale |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 92,391 5.800% |
-2,212 (-2.34%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 112,656 7.100% |
18,300 (+19.39%) |
Filing History |
| 2023-02-13 08:25 am Purchase |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital LLC | 157,934 9.900% |
29,402 (+22.88%) |
Filing History |
| 2023-02-09 10:34 am Sale |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-96,785 (Position Closed) |
Filing History |
| 2023-02-08 4:58 pm Purchase |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Lawrence M. Blatt, Ph.D. | 107,119 6.500% |
6,744 (+6.72%) |
Filing History |
| 2022-12-27 5:06 pm Purchase |
2022-12-16 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 94,356 5.900% |
94,356 (New Position) |
Filing History |
| 2022-02-14 4:55 pm Purchase |
2022-02-04 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital LLC | 128,532 7.500% |
128,532 (New Position) |
Filing History |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 0 0.000% |
-114,911 (Position Closed) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Baker Bros. Advisors LP | 83,056 5.300% |
83,056 (New Position) |
Filing History |
| 2022-02-14 4:08 pm Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 94,603 5.600% |
8,000 (+9.24%) |
Filing History |
| 2022-02-14 08:20 am Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
JANUS HENDERSON GROUP PLC JHG |
96,785 5.700% |
96,785 (New Position) |
Filing History |
| 2022-02-10 4:19 pm Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Beigelman Leonid | 74,894 4.700% |
3,000 (+4.17%) |
Filing History |
| 2022-02-10 4:15 pm Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Lawrence M. Blatt, Ph.D. | 100,375 6.200% |
4,500 (+4.69%) |
Filing History |
| 2022-02-10 07:48 am Sale |
2022-01-31 | 13G | Aligos Therapeutics, Inc. ALGS |
WELLINGTON MANAGEMENT CO LLP | 52,173 3.060% |
-90,306 (-63.38%) |
Filing History |
| 2022-02-04 09:12 am Sale |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
WELLINGTON MANAGEMENT CO LLP | 142,479 8.360% |
-14,625 (-9.31%) |
Filing History |
| 2022-02-04 08:53 am Purchase |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 48,248 2.830% |
48,248 (New Position) |
Filing History |
| 2022-01-31 4:28 pm Sale |
2022-01-28 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 78,000 4.900% |
-26,583 (-25.42%) |
Filing History |
| 2021-08-13 12:27 pm Purchase |
2021-08-03 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 114,911 6.700% |
114,911 (New Position) |
Filing History |
| 2021-06-21 4:44 pm Sale |
2021-06-11 | 13D | Aligos Therapeutics, Inc. ALGS |
Versant Venture Capital VI, L.P. | 58,317 3.800% |
-19,439 (-25.00%) |
Filing History |
| 2021-06-21 4:30 pm Unchanged |
2021-06-17 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 104,583 7.500% |
0 (Unchanged) |
Filing History |